The competition was strong for #BIO2018’s Buzz of BIO contest but only one winner from each category, “Technologies of Tomorrow” and “Pipelines of Promise,” could come out on top of the voting. Avery Therapeutics took the crown for “Technologies of Tomorrow” and biomarck Pharmaceuticals achieved the top spot in the “Pipelines of Promise” category. Buzz of BIO winners receive one complimentary Convention Access & Partnering registration pass and the opportunity to give a Company Presentation in front of industry colleagues at BIO’s convention.
Both companies, along with many others, will be presenting at the 2018 BIO International Convention in Boston this June 4-7, an opportunity conducive to increasing visibility and attracting more partners at the event. Presenting biotechs pitch their companies’ stories, pipelines, and objectives to a global audience representing more than 70 countries. Company Presentations are open to all BIO International Convention registrants.
“Technologies of Tomorrow” winner, Avery Therapeutics, is a startup company dedicated to advancing tissue-engineered therapeutics to treat diseases and injuries to human muscle. Avery’s novel engineered tissue platform enhances cell therapy delivery by targeting the root cause of degenerative disease. Avery’s MyCardia™ treatment for heart failure demonstrated pre-clinical functional improvements anticipated to translate to a significant improvement in quality of life.
Winner of the “Pipelines of Promise” category, biomarck Pharmaceuticals, is developing its lead compound, BIO-11006 for non-small cell lung cancer (NSCLC) and acute respiratory distress syndrome (ARDS). They have active INDs for both indications and are conducting Phase 2 clinical studies in patients with NCSLC and ARDS in 2017/2018.
BIO is still accepting applications to deliver a company presentation. Gain access to business development executives, investors, research analysts, policy makers, and media, and get more activity in BIO One-on-One Partnering™ by presenting. Click here to learn more about Company Presentations and for application instructions.
0 Comments
Comments are closed.